# Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

> **NCT07500259** · — · NOT_YET_RECRUITING · sponsor: **Luxembourg Institute of Health** · enrollment: 188 (estimated)

## Conditions studied

- Colorectal Cancer
- PDAC - Pancreatic Ductal Adenocarcinoma

## Interventions

- **OTHER:** Personalized Functional Profiling

## Key facts

- **NCT ID:** NCT07500259
- **Lead sponsor:** Luxembourg Institute of Health
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2029-09-30
- **Final completion:** 2034-11-01
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2026-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07500259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07500259, "Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07500259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*